IntelGenx Technologies Corp. (CVE:IGX – Get Free Report)’s share price traded up 1.8% during mid-day trading on Monday . The company traded as high as C$0.60 and last traded at C$0.58. Approximately 11,848 shares were traded during trading, a decline of 79% from the average daily volume of 56,279 shares. The stock had previously closed at C$0.57.
IntelGenx Technologies Trading Up 1.8%
The company’s 50 day moving average price is C$0.58 and its two-hundred day moving average price is C$0.58. The company has a debt-to-equity ratio of 164.62, a current ratio of 2.77 and a quick ratio of 2.69. The stock has a market capitalization of C$87.32 million and a PE ratio of -7.44.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
Featured Stories
- Five stocks we like better than IntelGenx Technologies
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
